One recent study, based on an analysis of adverse event reports submitted to the Food and Drug Administration, found a greater risk of abuse among patients taking semaglutide, the active ingredient in Wegovy and Ozempic, compared to other weight loss drugs
The article Semaglutide vs
If you have a pre-existing GI condition, discussing a slower dose escalation schedule with your provider is strongly recommended
Your healthcare provider will assess whether you meet FDA criteria for weight loss medication, which includes BMI thresholds and presence of weight-related comorbidities
For specific compound pharmacy formulations, charts like the compound tirzepatide dosage chart and the tirzepatide compound dosing chart account for the variations in concentration that different pharmacies provide
Given this, you want to store your pens away from windows and direct sunlight